Trials / Completed
CompletedNCT01720381
OptiScanner Versus Standard Blood Glucose Monitoring
Manual vs. Automated moNitoring Accuracy of GlucosE II (MANAGE II)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- OptiScan Biomedical Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is to demonstrate the accuracy of the OptiScanner in measuring blood glucose levels in critically ill patients when compared to a reference YSI 2300 STAT Plus and the Gem 3000, the reference standard for Erasme University Hospital.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-11-02
- Last updated
- 2014-06-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01720381. Inclusion in this directory is not an endorsement.